CANCER CELL APOPTOSIS
- 专利权人:
- E-THERAPEUTICS PLC
- 发明人:
- 申请号：
- IL218008
- 公开号：
- IL218008A
- 申请日:
- 2012.02.09
- 申请国别(地区):
- IL
- 年份:
- 2012
- 代理人:
- 摘要：
- There is especially described dexanabinol, or a derivative thereof, as the therapeutic agent.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- CANCER CELL APOPTOSIS
- COMPOSITION PHARMACEUTIQUE CONTENANT UN DÉRIVÉ D'ACIDE AMINÉ MARQUÉ AU 211AT, ET PROCÉDÉ POUR PRODUIRE LADITE COMPOSITION PHARMACEUTIQUE
- Dexanabinol or a derivative thereof for use in the treatment of cancer in dose ranges of 2-30 mg/kg
- Dexanabinol or a derivative thereof for use in treating cancer at doses ranging from 2 to 30 mg / kg
- Dexanabinol or a Derivative Thereof for Use in the Treatment of Cancer in Dose Ranges of 2-30 mg/kg
